These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 10831636)
1. Steroid and cyclophosphamide in IgA nephropathy. Roccatello D; Ferro M; Cesano G; Rossi D; Berutti S; Salomone M; Piccoli G; Sena LM Nephrol Dial Transplant; 2000 Jun; 15(6):833-5. PubMed ID: 10831636 [TBL] [Abstract][Full Text] [Related]
2. Long-term effects of methylprednisolone pulses and mycophenolate mofetil in IgA nephropathy patients at risk of progression. Roccatello D; Rossi D; Marletto F; Naretto C; Sciascia S; Baldovino S; Piras D; Giachino O J Nephrol; 2012; 25(2):198-203. PubMed ID: 21725921 [TBL] [Abstract][Full Text] [Related]
3. Crescentic, proliferative IgA nephropathy: clinical and histological response to methylprednisolone and intravenous cyclophosphamide. Tumlin JA; Lohavichan V; Hennigar R Nephrol Dial Transplant; 2003 Jul; 18(7):1321-9. PubMed ID: 12808169 [TBL] [Abstract][Full Text] [Related]
4. IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine. Pozzi C; Andrulli S; Pani A; Scaini P; Roccatello D; Fogazzi G; Pecchini P; Rustichelli R; Finocchiaro P; Del Vecchio L; Locatelli F J Nephrol; 2013; 26(1):86-93. PubMed ID: 22460183 [TBL] [Abstract][Full Text] [Related]
5. Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment. McIntyre CW; Fluck RJ; Lambie SH Clin Nephrol; 2001 Sep; 56(3):193-8. PubMed ID: 11597033 [TBL] [Abstract][Full Text] [Related]
6. Behcet's disease and IgA nephropathy: report of this association in a patient from Brazil and literature review. Fernandes PF; Júnior GB; Barros FA; Sousa DC; Franco LM; Patrocínio RM Invest Clin; 2006 Dec; 47(4):405-11. PubMed ID: 17176908 [TBL] [Abstract][Full Text] [Related]
7. Clinical presentation, natural history, and treatment of crescentic proliferative IgA nephropathy. Tumlin JA; Hennigar RA Semin Nephrol; 2004 May; 24(3):256-68. PubMed ID: 15156530 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of methylprednisolone, cyclophosphamide in pediatric IgA nephropathy assessed by renal biopsy. Jiang XY; Mo Y; Sun LZ; Yue ZH; Chen SM; Wu W Clin Nephrol; 2009 Jun; 71(6):625-31. PubMed ID: 19473630 [TBL] [Abstract][Full Text] [Related]
9. Comparison of antiproteinuric effects of two different combination therapies in children with IgA nephropathy. Yagi K; Okada M; Yanagida H; Kuwajima H; Ikeda M; Sugimoto K; Takemura T Clin Exp Nephrol; 2003 Dec; 7(4):270-4. PubMed ID: 14712355 [TBL] [Abstract][Full Text] [Related]
10. Report on intensive treatment of extracapillary glomerulonephritis with focus on crescentic IgA nephropathy. Roccatello D; Ferro M; Coppo R; Giraudo G; Quattrocchio G; Piccoli G Nephrol Dial Transplant; 1995 Nov; 10(11):2054-9. PubMed ID: 8643167 [TBL] [Abstract][Full Text] [Related]
11. [Immunosuppressive therapy in IgA glomerulonephritis with chronic renal failure: case study presentation and literature review]. Pozzi C; Del Vecchio L; Locatelli F G Ital Nefrol; 2002; 19(5):523-8. PubMed ID: 12439840 [TBL] [Abstract][Full Text] [Related]
12. Idiopathic IgA nephropathy with segmental necrotizing lesions of the capillary wall. D'Amico G; Napodano P; Ferrario F; Rastaldi MP; Arrigo G Kidney Int; 2001 Feb; 59(2):682-92. PubMed ID: 11168950 [TBL] [Abstract][Full Text] [Related]
13. Mycophenolate Mofetil Combined With Prednisone Versus Full-Dose Prednisone in IgA Nephropathy With Active Proliferative Lesions: A Randomized Controlled Trial. Hou JH; Le WB; Chen N; Wang WM; Liu ZS; Liu D; Chen JH; Tian J; Fu P; Hu ZX; Zeng CH; Liang SS; Zhou ML; Zhang HT; Liu ZH Am J Kidney Dis; 2017 Jun; 69(6):788-795. PubMed ID: 28215945 [TBL] [Abstract][Full Text] [Related]
14. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group. Branten AJ; Wetzels JF Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653 [TBL] [Abstract][Full Text] [Related]
15. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits. Haas M; Jafri J; Bartosh SM; Karp SL; Adler SG; Meehan SM Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672 [TBL] [Abstract][Full Text] [Related]
16. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy. Manno C; Torres DD; Rossini M; Pesce F; Schena FP Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647 [TBL] [Abstract][Full Text] [Related]
17. [Multicenter investigation of therapeutic status of children with IgA nephropathy in China]. Working Group for National Survey on Status of Diagnosis and Treatment of Childhood Renal Diseases Zhonghua Er Ke Za Zhi; 2013 Jul; 51(7):486-90. PubMed ID: 24267127 [TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive treatment of the nephrotic syndrome due to mesangial lesions. Faedda R; Pirisi M; Satta A; Tanda F; Bartoli E Clin Nephrol; 1996 Oct; 46(4):237-44. PubMed ID: 8905208 [TBL] [Abstract][Full Text] [Related]
19. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate. du Buf-Vereijken PW; Branten AJ; Wetzels JF; Nephrol Dial Transplant; 2004 May; 19(5):1142-8. PubMed ID: 14993502 [TBL] [Abstract][Full Text] [Related]
20. [Steroid-responsive nephrotic syndrome in IgA nephropathy]. García Camín RM; Cabezas A; Calero F; Ballarín JA Nefrologia; 2004; 24 Suppl 3():68-71. PubMed ID: 15219073 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]